These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22154192)

  • 1. Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis.
    Nie X; Cai G; Zhang W; Wang H; Wu B; Li Q; Shen Q
    Clin Immunol; 2012 Mar; 142(3):269-79. PubMed ID: 22154192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-α Regulates Mast Cell Functions by Inhibiting Cell Degranulation.
    Gao Y; Xu B; Zhang P; He Y; Liang X; Liu J; Li J
    Cell Physiol Biochem; 2017; 44(2):751-762. PubMed ID: 29169157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
    Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
    Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
    Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
    Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cells in vitro.
    Klingenberg R; Autschbach F; Gleissner C; Giese T; Wambsganss N; Sommer N; Richter G; Katus HA; Dengler TJ
    Eur J Immunol; 2005 Jun; 35(6):1712-21. PubMed ID: 15864782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
    Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
    Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice.
    Hamel KM; Cao Y; Olalekan SA; Finnegan A
    Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells.
    Vosskuhl K; Greten TF; Manns MP; Korangy F; Wedemeyer J
    J Immunol; 2010 Jul; 185(1):119-25. PubMed ID: 20511546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and distinct signalling cascades in the production of tumour necrosis factor-alpha and interleukin-13 induced by lipopolysaccharide in RBL-2H3 cells.
    Gon Y; Nunomura S; Ra C
    Clin Exp Allergy; 2005 May; 35(5):635-42. PubMed ID: 15898987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
    Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
    Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
    Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
    Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming.
    Ogata M; Ito T; Shimamoto K; Nakanishi T; Satsutani N; Miyamoto R; Nomura S
    Int Immunol; 2013 Mar; 25(3):171-82. PubMed ID: 23125331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
    Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function.
    Dudeck A; Suender CA; Kostka SL; von Stebut E; Maurer M
    Eur J Immunol; 2011 Jul; 41(7):1883-93. PubMed ID: 21491417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of CD4+ T cells in the decision between tolerance and immunity in vivo reveals a pivotal role for ICOS.
    Lischke T; Hegemann A; Gurka S; Vu Van D; Burmeister Y; Lam KP; Kershaw O; Mollenkopf HJ; Mages HW; Hutloff A; Kroczek RA
    J Immunol; 2012 Jul; 189(1):234-44. PubMed ID: 22661090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
    Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
    Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of D3R on TLR4 signaling involved in the regulation of METH-mediated mast cells activation.
    Xue L; Geng Y; Li M; Jin YF; Ren HX; Li X; Wu F; Wang B; Cheng WY; Chen T; Chen YJ
    Int Immunopharmacol; 2016 Jul; 36():187-198. PubMed ID: 27156126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.